During the past decade, Universitatsklinikum fur Innere Medizin II conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitatsklinikum fur Innere Medizin II" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Actelion" with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Foundation for Cardiovascular Research, Zurich" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitatsklinikum fur Innere Medizin II" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitatsklinikum fur Innere Medizin II" are "Pulmonary Arterial Hypertension" (3 trials), "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials), "Coronary Arteriosclerosis" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Universitatsklinikum fur Innere Medizin II" in a lesser frequency.

Most popular intervention types in "Universitatsklinikum fur Innere Medizin II" are "Drug" (6 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ralinepag" (2 trials), "XIENCE V®/ XIENCE PRIME™" (2 trials), "CYPHER SELECT" (1 trials), "Edoxaban-based Regimen" (1 trials) and "Medical antitrhombotic treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinikum fur Innere Medizin II" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Universitatsklinikum fur Innere Medizin II". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Universitatsklinikum fur Innere Medizin II, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinikum fur Innere Medizin II, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".